Treatment
Equecabtagene Autoleucel clinical trials
We’re tracking 3 recruiting studies that include Equecabtagene Autoleucel, each written for real people, not researchers, below.
Recruiting studies
- NCT07028970Recruiting
Long-term follow-up study for equecabtagene autoleucel recipients
This registry study will follow people who have received the CAR T-cell therapy equecabtagene autoleucel to monitor their long-term health and outcomes. It is open to those who completed or withdrew from an earlier study of this treatment.
BeijingAges Any age - NCT06902844Recruiting
Eque-cel for lupus that has not responded to other treatments
This trial tests a new cell therapy called eque-cel for people with lupus that has come back or is not controlled by standard treatments. It aims to see if this therapy can reduce lupus activity and improve symptoms.
Wuhan, HubeiAges 18 years+ - NCT06464991RecruitingPhase 3
Eque-cel for Lenalidomide-Refractory Multiple Myeloma
This study tests a new CAR-T cell therapy called Eque-cel for people with multiple myeloma that no longer responds to lenalidomide. It aims to see if this treatment can help control the disease after 1-2 prior therapies.
BeijingAges 18–75
What Equecabtagene Autoleucel is being studied for
Conditions with recruiting Equecabtagene Autoleucel studies.
Common questions
- Are there clinical trials studying Equecabtagene Autoleucel?
- Yes. Clin2 currently lists 3 recruiting studies that include Equecabtagene Autoleucel, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Equecabtagene Autoleucel trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Equecabtagene Autoleucel an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Equecabtagene Autoleucel or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.